Oral administration of 1 alpha hydroxyvitamin D3 inhibits tumor growth and metastasis of a murine osteosarcoma model

Anticancer Research

Volumn 21, Issue 1 A, 2001, Pages 321-324

  Hara, K ^a   Kusuzaki, K ^a   Takeshita, H ^a   Kuzuhara, A ^a   Tsuji, Y ^a   Ashihara, T ^a   Hirasawa, Y ^a  

^a Otsu Municipal Hospital   (Japan)

Author keywords

1 alpha hydroxyvitamin D3; Osteosarcoma; Tumor growth

Indexed keywords

CALCITRIOL; DOXORUBICIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER SIZE; CELL CYCLE; CONTROLLED STUDY; CYTOFLUOROMETRY; DOSE RESPONSE; DRUG POTENTIATION; HISTOPATHOLOGY; LUNG METASTASIS; MITOSIS; MOUSE; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR NECROSIS;

ADMINISTRATION, ORAL; ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CELL CYCLE; CELL DIVISION; DOXORUBICIN; HYDROXYCHOLECALCIFEROLS; LUNG NEOPLASMS; MICE; MICE, INBRED C3H; OSTEOSARCOMA; TUMOR CELLS, CULTURED;

EID: 0035061146     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Newly identified actions of the vitamin D endocrine system
2. Vitamin D: New actions, new analogues, new therapeutic potential
3. Differentiation of mouse myeloid leukemia cells induced by 1 alpha, 25-dihydroxyvitamin D3
4. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system
5. 1,25-Dihydroxyvitamin D3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition
6. Vitamin D analogues up-regulate p21 and p27 during growth inhibition of pancreatic cancer cell lines
7. Effects of synthetic analogues on breast cancer cell proliferation in vivo and in vitro
8. Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25 dihydroxyvitamin D3
9. Antiproliferative effects in vitro and in vivo of 1,25-dihydroxyvitamin D3 and a vitamin D3 analog in a squamous cell carcinoma system
10. DNA/RNA ratios in bone and soft tissue tumors: A novel index for the assessment of cell function and malignancy
11. The nuclear receptor superfamily: The second decade
12. Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system
13. 1,25-Dihydroxyvitamin D3 regulation of human cancer cell replication
14. Rapid control of transmembrane calcium influx by 1 alpha, 25-dihydroxyvitamin D3 and its analogues in rat osteoblast-like cells
15. 1,25-Dihydroxyvitamin D3 induces programed cell death in a rat glioma cell line
16. Combination of a potent 20-epi-vitamin D3 analogue (KH1060) with 9-cis-retinoic acid irreversively inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells
17. Differential apoptotic response of human melanoma cells to 1 alpha,25-dihydroxyvitamin D3 and its analogues
18. Vitamin D3 is a potent inhibitor of tumor cell-induced angiogenesis
19. 1,25-Dihydroxyvitamin D3 enhances the susceptibility of breast cancer cells to doxorubicin-induced oxidative damage